Latest filing published 14 Nov 2019 for Bellicum Pharmaceuticals, INC.
Insider track record
No signal scores available.
Jr Joseph Paul Woodard: trading record in brief
All filings by Jr Joseph Paul Woodard on record concern Bellicum Pharmaceuticals, Inc. Altogether 2 filings, all relating to 13 November 2019.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 14 November 2019 came the latest disclosure, an option exercise in Bellicum Pharmaceuticals, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jr Joseph Paul Woodard
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,750 sharesCommon StockSEC:0001773944-19-000002:0
- 1,597 shares@ US$0.82100.0% of flowCommon StockSEC:0001773944-19-000002:1
2 of 2 declarations
